New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.
Researchers sought to characterize the incidence and risk factors for thrombotic events in patients with secondary myelofibrosis.
Investigators sought to assess the effectiveness of heparin in patients hospitalized with COVID-19 and hypercoagulation.
Researchers sought to determine whether patients with virologically suppressed HIV were more likely to have impaired markers of fibrinolysis.
Researchers sought to determine whether neutrophil-to-lymphocyte ratio would be predictive of thrombotic events in patients with polycythemia vera.
Investigators sought to determine the safety and efficacy of varying doses of enoxaparin regimens in patients receiving a bariatric procedure.
Researchers sought to determine whether there was a higher risk of developing thrombosis in patients with MPNs and COVID-19.
The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis.
Researchers sought to determine rates of stroke, stroke-related disability, and presence of neuropsychiatric symptoms in patients with hTTP.
Researchers sought to determine the patterns of coagulation times with concentration of dabigatran in adults and children with VTE.
In an observational study, researchers examined certified stroke center care access between historically underserved and general communities.
Researchers sought to determine whether azathioprine should be evaluated as an option for second-line therapy in patients with of immune-related TTP.
Researchers sought to determine whether prespecified outcomes were different in endovascular thrombectomy with alteplase compared with EVT alone in patients hospitalized with acute ischemic stroke.
Researchers sought to determine whether an assay using flow cytometry may help to diagnose patients who have vaccine-induced immune thrombotic thrombocytopenia.
Researchers sought to determine whether prophylaxis with enoxaparin would be effective in outpatients with COVID-19.
Researchers sought to determine whether thromboprophylaxis with enoxaparin would reduce early hospitalizations and deaths among outpatients with symptomatic COVID-19.
Researchers sought to determine whether there was a link between anti-endothelial cell antibodies and thrombosis in patients with polycythemia vera.
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Researchers sought to determine whether avatrombopag with MSCs would improve platelet recovery in patients with prolonged thrombocytopenia after allo-HSCT.
Researchers sought to determine whether the incidence of CAT was different across designated racial groups.
Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.
Researchers sought to determine the factors that contribute to patients developing clots from Long COVID.
Researchers sought to assess whether patients with migraine had a greater risk for PCiS than ACiS and if patients genetically predisposed to migraine showed an increased risk for PCiS or ACiS.
Researchers sought to determine whether the Khorana score would be able to risk-stratify patients according to the 6-month risk of incident VTE.
Researchers sought to determine whether fondaparinux would be a more cost-effective treatment compared with argatroban in patients with suspected HIT.
What is the best current strategy for addressing patients with COVID-19 who are at high risk for thrombosis but are not in the ICU?
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Medulloblastoma survivors had an increased risk of long-term adverse outcomes.
Researchers sought to compare the efficacy of momelotinib with danazol in patients with thrombocytopenic myelofibrosis who were symptomatic and anemic.
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Researchers sought to determine whether catheter-directed thrombolysis would be effective in patients with postpartum iliofemoral deep venous thrombosis.
Researchers are seeking to address the psychological impact of patients who have survived VTE.
Researchers sought to determine whether rilzabrutinib would be effective in treating immune thrombocytopenia.
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.
Researchers sought to assess any recent changes in racial inequities trends in stroke treatment and in-hospital mortality, and whether racial inequities differed among patients living in rural areas.
Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.
Researchers sought to determine whether patients with thrombotic antiphospholipid syndrome may be at greater risk of stroke when treated with apixaban instead of warfarin.
Researchers sought to determine whether adding prednisone to sirolimus would improve outcomes in patients with Kasabach-Merritt phenomenon of kaposiform hemangioendothelioma.
Is there a relationship between OSA and cognitive impairment in patients with minor ischemic stroke?
In a prospective, longitudinal study, researchers determined the rates and factors associated with recurrent ischemic stroke, death, and new-onset atrial fibrillation among young adults.
The AHA and the ASA released a joint scientific statement on the use of endovascular therapy or thrombolysis in adult patients with preexisting dementia or disability.
Researchers investigated whether thrombophilia in patients with IBD significantly contributes to developing venous thromboembolic events.
Researchers sought to determine the risk factors for both venous and arterial thrombosis in neonates admitted to neonatal intensive care units.
Two studies show increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S
Researchers sought to determine the state of detection and initiation of prophylactic treatment for patients with hTTP.
A recent study sought to refine international risk classification guidelines on preventing VTE after discontinuation of anticoagulation therapy.
Investigators compared outcomes of thrombolytic therapy and surgery as first-line treatment for patients with obstructive prosthetic valve thrombosis.
Researchers sought to determine the cost-effectiveness of eltrombopag for patients with immune thrombocytopenia compared with intravenous immunoglobulin.
Researchers sought to determine the underlying reasons for thrombosis risk in patients with severe COVID-19.
A study sought to determine whether overweight/obesity is a factor in the development of thrombosis in cancer patients with peripherally inserted central catheters.
Researchers sought to determine whether interferon-alpha or hydroxyurea would be effective treatments for patients with essential thrombocythemia and polycythemia vera.